more_reports

Soligenix Inc.

SNGX:NASDAQ

Soligenix is a late stage biopharmaceutical company committed to developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense. Soligenix has two areas of focus: 1) a therapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need such as cutaneous T-cell lymphoma, oral mucositis, pediatric Crohn's disease, acute radiation enteritis, and 2) a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, gastrointestinal acute radiation syndrome, and melioidosis.

streetwise book logo Streetwise Company Fact Sheet

2024/7/22 12:34:46

(SNGX:NASDAQ)

Streetwise Reports Articles

07/27/2022 - View Article